Recent Events & Catalysts
Apogee Therapeutics, Inc. (APGE) — real, dated facts. Not a claim about what caused any single day's price move.
Committee Signals
Proprietary signals generated by the Innellis AI committee — score changes, rating shifts, and analyst disagreements.
No committee signals recorded yet.
News
Apogee Therapeutics Q2 EPS $(1.14) Misses $(1.05) Estimate
Benzinga · 1d ago
AbbVie (ABBV) Is Down 5.3% After Raising 2026 Revenue Outlook and Issuing New Debt - What's Changed
Yahoo · 4d ago
Baron Capital Exits Apogee Therapeutics (APGE) Following AbbVie Buyout
Yahoo · 6d ago
Sector Update: Healthcare Stocks Softer Late Afternoon
Yahoo · 7d ago
Merck, Pfizer Lift Full-Year Sales Outlooks Following Second-Quarter Beats
Yahoo · 7d ago
'AbbVie Seeks at Least $8 Billion in Debt to Fund Apogee Deal' - Bloomberg
Benzinga · 7d ago
Is Apogee Therapeutics (APGE) Fully Priced, Or Still A Bargain?
Yahoo · 8d ago
ABBV Q2 Earnings Call Balances Growth With Apogee Dilution
Yahoo · 8d ago
SEC Filings (90 days)
Departure/appointment of directors or officers, Submission of matters to a vote of security holders
Filed 2026-08-11 · 0d ago
Results of operations (earnings release), Financial statements and exhibits
Filed 2026-08-10 · 1d ago · Material
Entry into a material agreement, Submission of matters to a vote of security holders, Regulation FD disclosure, Other events, Financial statements and exhibits
Filed 2026-06-22 · 50d ago
Entry into a material agreement, Financial statements and exhibits
Filed 2026-06-22 · 50d ago
Submission of matters to a vote of security holders
Filed 2026-06-12 · 60d ago
Earnings
No recent earnings data available.
Latest Analyst Action
No recent analyst actions available.